A phase 2 double blind placebo controlled multi-centre adaptive design study to assess the dose-response relationship, safety & toleration of Uk-279,276 in acute stroke

  • Bladin, Christopher (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/01/01 → 31/12/02